Enlimomab acute stroke trial (east): Trial of the efficacy and safety of enlimomab (anti-ICAM-1) compared to placebo for treatment of acute ischemic stroke: Stephen H. Polmar, and David S. Sherman (Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT and Cerebro Vascular Advances, Inc., San Antonio, TX)

• Book ID: 117707241
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 254 KB
• Volume: 6
• Category: Article
• ISSN: 1532-8511
• DOI: 10.1016/s1052-3057(97)80262-5